cheynew, I think that the HGEN stock reacts well to drama. While the market knows that the EUA has been filed, that it will get a response any time now, and that the general believe of its shareholders that the EUA will be granted, I am careful. If Wall St knows everyone expect a big up, then if they can engineer a big down, it is exactly what they do. That is what I like about CDMO, no jumps in either direction expected but slow pace moves.
Hence the HGEN PPS currently moves on play. And if I put it in that context then I will say yes it will probably react on the news.
However, I am not sure how. I have myself a very small position in HGEN and was about to sell it because I am moving direction LOSS. I bought 5K in MAR 2021 at an average of 15.30$. So not a big loss if I need to sell at 10$, but if it explodes then I am not missing the boat.
Yet, golfho's post on the HGEN board made me doubt. I don't know HGEN that good compared to CDMO. And, just like you, I know about the PPS of companies that have clinical trials running.
Golfho's arguments where very strong in that the agencies are behind HGEN. But as I posted, I am not sure the revenue, with the needed margins, will be there (at least COVID related one) in the extend expected by the market. Therefore, I have also lowered my short-term production expectations in CDMO for HGEN.
It's a difficult one.
AIMO
News 
Market Data 
Discover 
